Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Braskem (BAK) Notes Payables (2017 - 2025)

Braskem has reported Notes Payables over the past 10 years, most recently at $1.5 billion for Q4 2025.

  • For Q4 2025, Notes Payables rose 291.24% year-over-year to $1.5 billion; the TTM value through Dec 2025 reached $1.5 billion, up 291.24%, while the annual FY2025 figure was $1.5 billion, 291.24% up from the prior year.
  • Notes Payables for Q4 2025 was $1.5 billion at Braskem, up from $392.0 million in the prior quarter.
  • Over five years, Notes Payables peaked at $1.5 billion in Q4 2025 and troughed at $28.5 million in Q3 2021.
  • A 5-year average of $477.9 million and a median of $327.3 million in 2022 define the central range for Notes Payables.
  • Biggest five-year swings in Notes Payables: decreased 4.36% in 2024 and later soared 291.24% in 2025.
  • Year by year, Notes Payables stood at $240.9 million in 2021, then increased by 9.07% to $262.7 million in 2022, then surged by 56.01% to $409.9 million in 2023, then fell by 4.36% to $392.0 million in 2024, then soared by 291.24% to $1.5 billion in 2025.
  • Business Quant data shows Notes Payables for BAK at $1.5 billion in Q4 2025, $392.0 million in Q4 2024, and $409.9 million in Q4 2023.